NEW YORK (GenomeWeb News) – Power3 Medical Products today announced a definitive agreement to acquire all the stock of stem cell firm Rozetta-Cell Life Sciences.
Upon completion of the deal, expected in October or November, Rozetta-Cell will be merged with Power3 and take its name.
Terms of the deal were not disclosed.